Summary & Overview
HCPCS G0518: Removal and Reinsertion of Non-Biodegradable Drug Delivery Implants, 4+
HCPCS Level II code G0518 designates the removal with reinsertion of non-biodegradable drug delivery implants when four or more subdermal implants are involved. This code captures a specific procedural scenario in implantable drug delivery management, relevant for surgical providers, ambulatory centers, and payers given its procedural complexity and potential impact on care coordination and reimbursement. Nationally, the code matters for tracking utilization of implant management services and ensuring accurate claims submission for multi-implant procedures.
Key payers covered in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical intent and typical settings of service, a summary of payer coverage considerations, and a focused look at common billing modifiers and administrative notes supplied in the input. The publication outlines what to expect from benchmarks and policy context where available and identifies areas where input data was not provided.
This summary is intended for a national audience of billing specialists, practice managers, and compliance staff who need a clear, actionable description of the code, its clinical use, and payer relevance. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G0518 describes removal with reinsertion of non-biodegradable drug delivery implants, four or more, a procedure typically performed for management of subdermal implantable drug devices. The service type is surgical removal and replacement of subdermal drug delivery implants when multiple non-biodegradable implants (four or more) are involved. The typical site of service is an outpatient surgical suite, ambulatory surgery center, or physician office procedural room depending on clinical complexity and facility capabilities.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 29-year-old cisgender female presents to an outpatient ambulatory surgery center for removal and immediate reinsertion of subdermal non-biodegradable contraceptive implants. She previously had four implants placed in the subdermal tissue of the medial upper arm for long-acting reversible contraception and is requesting replacement after device expiration. The patient is evaluated pre-procedure for anticoagulation status, allergy history, and prior implant location and scarring. Local anesthesia is planned. The clinician confirms informed consent and documents device counts, laterality, and planned technique for removal and reinsertion. The workflow includes time-out, sterile prep, local infiltration with lidocaine, small incisions or explantation via palpation-guided extraction, removal of all four devices, and placement of four new non-biodegradable implants in the subdermal plane. Hemostasis is obtained, wounds are closed with sterile strips or simple sutures, and post-procedure instructions for wound care and activity are given. Typical billing uses HCPCS Level II code G0518 for removal with reinsertion of non-biodegradable drug delivery implants, 4 or more. Usual sites of service are outpatient ambulatory surgery center, hospital outpatient department, or office-based procedure rooms.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default — No modifier | When no specific modifier applies and no additional reporting is required. |